Skip to content
Subsido
OpenGrantEuropean Commission

Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases

- Clinical researchers and developers have access to novel predictive biomarkers to guide a more accurate assessment of disease progression and treatment response and tackle the unmet clinical needs of non-communicable chronic diseases. - Clinicians and healthcare professionals use clinically validated predictive biomarkers for implementing more effective clinical research and personalised medicine with better health outcomes in chronic non-communicable diseases.

Key facts

Status
Open
Kind of support
Grant
Call
Horizon Europe · Cluster 1 - Health (Two stage - 2027) · HORIZON-HLTH-2027-02-two-stage
Company size
No restriction published
Where
European Union

Conditions

The conditions for qualifying. An eligibility check tests your details against each one.

  • At least 3 independent partners

Does your company qualify?

Give a few facts about your company and project, and see for each condition whether you meet it.

Eligibility check

Similar measures

OpenGrantEuropean Commission

Neutral-Atom Platform Technologies

- Fully programmable industry-ready quantum simulators based on 10.000 neutral atoms in a scalable architecture, accessible via cloud platforms, and with the possibility of integrating them…

Deadline 17 Nov 2026(3 days left)up to €20.0MEuropean Union
DigitalisationInnovationResearch and development

A check is an indication from the published conditions and the facts you give. Only the competent authority decides whether you are eligible.